TILMICOSIN
UNII XL4103X2E3

Substance Identification & Data

This profile provides standardized clinical and technical data for Tilmicosin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) XL4103X2E3.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 108050-54-0 and the RxNorm Concept ID (RxCUI) 38278. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

XL4103X2E3

CAS Registry Number

108050-54-0

RxNorm Concept ID

38278

Detailed Substance Profile

Preferred Name

TILMICOSIN

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

XL4103X2E3

The specific atomic composition represented as a molecular structure string.

InChIKey

C46H80N2O13

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

JTSDBFGMPLKDCD-XVFHVFLVSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C84213

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

5282521

Unique identification number in the NCBI database of chemical substances.

INN ID

6024

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

X-93

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

O[C@@H]1CC(=O)O[C@H](CC)[C@@H](CO[C@@H]2O[C@@H]([C@H]([C@H]([C@H]2OC)OC)O)C)/C=C(\C)/C=C/C([C@@H](C[C@H](CCN3C[C@@H](C[C@@H](C3)C)C)[C@H](O[C@@]4([H])[C@H](O)[C@H]([C@H](O)[C@H](O4)C)N(C)C)[C@H]1C)C)=O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Tilmicosin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.